Columbus, OH – Using artificial intelligence to monitor patient adherence?

“Sounds too good to be true”

“We’re too many years out”

“Too expensive”

But AiCure has done just that (although at $12.25 million in funding, the expensive part is true). Their AI Platform provides an intuitive monitoring program that uses facial recognition and sensors found in your mobile device to confirm whether or not a patient has taken their medication and then relay that data back to the provider. (See their demo video for proof:

AiCure has been partnering with pharmaceutical companies to gain traction in the adherence space and as AiCure, and other adherence products like it, become mainstream, they offer a new, promising channel for delivering branded adherence content to help patients stay on track.

About the Author:

Jeffrey Giermek